000 01177 a2200349 4500
005 20250515132046.0
264 0 _c20081001
008 200810s 0 0 eng d
022 _a1871-5206
040 _aNLM
_beng
_cNLM
100 1 _aHénon, Hélène
245 0 0 _aPyrrolocarbazoles as checkpoint 1 kinase inhibitors.
_h[electronic resource]
260 _bAnti-cancer agents in medicinal chemistry
_cAug 2008
300 _a577-97 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Review
650 0 4 _aCarbazoles
_xpharmacology
650 0 4 _aCheckpoint Kinase 1
650 0 4 _aCyclization
650 0 4 _aHumans
650 0 4 _aImidazoles
_xchemical synthesis
650 0 4 _aModels, Biological
650 0 4 _aModels, Molecular
650 0 4 _aProtein Kinase Inhibitors
_xchemical synthesis
650 0 4 _aProtein Kinases
_xmetabolism
650 0 4 _aPyrroles
_xchemical synthesis
700 1 _aConchon, Elisabeth
700 1 _aHugon, Bernadette
700 1 _aMessaoudi, Samir
700 1 _aGolsteyn, Roy M
700 1 _aPrudhomme, Michelle
773 0 _tAnti-cancer agents in medicinal chemistry
_gvol. 8
_gno. 6
_gp. 577-97
999 _c18165103
_d18165103